[go: up one dir, main page]

MX9700338A - Derivados heterociclicos de azolona anti-helicobacter. - Google Patents

Derivados heterociclicos de azolona anti-helicobacter.

Info

Publication number
MX9700338A
MX9700338A MX9700338A MX9700338A MX9700338A MX 9700338 A MX9700338 A MX 9700338A MX 9700338 A MX9700338 A MX 9700338A MX 9700338 A MX9700338 A MX 9700338A MX 9700338 A MX9700338 A MX 9700338A
Authority
MX
Mexico
Prior art keywords
4alkyl
optionally substituted
alkyloxy
compounds
azolones
Prior art date
Application number
MX9700338A
Other languages
English (en)
Inventor
Jan Heeres
Raymond Antoine Stokbroekx
Marc Willems
Robert Josef Maria Hendrickx
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of MX9700338A publication Critical patent/MX9700338A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Polymerization Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invencion se refiere a los compuesto que tienen la formula (I), las sales de adicion farmacéuticamente aceptables y las formas esteroquímicamente isomericas de las mismas, en donde Y es CH o N; R1, R2, y R3 cada uno independientemente es hidrogeno o alquilo de C1-4; R4 y R5 son cada uno independientemente hidrogeno, halogeno, alquilo de C1-4; alquiloxi de C1-4; hidroxilo, trifluorometilo, trifluorometiloxi o difluorometiloxi; R6 es piridinilo opcionalmente sustituido hasta con dos grupos alquilo C1-4; y (alquilo C1-4) hidroxipiridinilo; y (alquilo C1-4) alquiloxipiridinilo de C1-4; piridizanilo opcionalmente sustituido con alquiloxi de C1-4; piridinilo opcionalmente sustituido con hidroxilo o alquiloxi de C1-4; tiazolilo opcionalmente sustituido con alquilo C1-4; tquiazolilo opcionalmente sustituido con alquilo de C1-4; benzoxazolilo o benzotiazolilo; o R6 es pirazinilo o piriddazinilo sustituido con alquilo C1-4; Z es C=O; y (a) es un radical de la formula (a-1), (a-2), (a-3), (a-4), (a-5), (a-6) o (a-7); composiciones que comprenden dichos compuestos, procedimientos para preparar los mismos y el uso de estos compuestos como una medicina.
MX9700338A 1994-07-12 1995-07-05 Derivados heterociclicos de azolona anti-helicobacter. MX9700338A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94202018 1994-07-12
PCT/EP1995/002616 WO1996001821A1 (en) 1994-07-12 1995-07-05 Anti-helicobacter heterocyclic derivatives of azolones

Publications (1)

Publication Number Publication Date
MX9700338A true MX9700338A (es) 1997-05-31

Family

ID=8217031

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9700338A MX9700338A (es) 1994-07-12 1995-07-05 Derivados heterociclicos de azolona anti-helicobacter.

Country Status (20)

Country Link
US (1) US5607932A (es)
EP (1) EP0770073A1 (es)
JP (1) JPH10502383A (es)
CN (1) CN1067999C (es)
AU (1) AU684986B2 (es)
BR (1) BR9508380A (es)
CA (1) CA2194563A1 (es)
CZ (1) CZ2697A3 (es)
FI (1) FI970110A0 (es)
HU (1) HUT76641A (es)
IL (1) IL114534A (es)
MX (1) MX9700338A (es)
MY (1) MY131785A (es)
NO (1) NO310289B1 (es)
NZ (1) NZ290116A (es)
PL (1) PL318142A1 (es)
RU (1) RU2152940C1 (es)
SK (1) SK2197A3 (es)
WO (1) WO1996001821A1 (es)
ZA (1) ZA955753B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100411190B1 (ko) * 1995-12-26 2004-03-26 에스케이케미칼주식회사 에틸렌글리콜의회수방법
CN1077892C (zh) * 1996-06-25 2002-01-16 武田药品工业株式会社 噁唑酮衍生物及其作为抗幽门螺杆菌剂的应用
KR20000005291A (ko) 1996-06-25 2000-01-25 다케다 야쿠힌 고교 가부시키가이샤 옥사졸론 유도체 및 항-헬리코박터 파일로리 제제로서의 이의용도
CN101084211A (zh) 2004-09-20 2007-12-05 泽农医药公司 杂环衍生物及其作为治疗剂的用途
WO2006034441A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
US7919496B2 (en) 2004-09-20 2011-04-05 Xenon Pharmaceuticals Inc. Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-CoA desaturase enzymes
AR051094A1 (es) 2004-09-20 2006-12-20 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como inhibidores de la estearoil-coa desaturasa
US7767677B2 (en) 2004-09-20 2010-08-03 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
CA2580844A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as mediators of stearoyl-coa desaturase
JP4958785B2 (ja) 2004-09-20 2012-06-20 ゼノン・ファーマシューティカルズ・インコーポレイテッド 複素環誘導体およびステアロイル−CoAデサチュラーゼインヒビターとしてのそれらの使用
EP2540296A1 (en) 2005-06-03 2013-01-02 Xenon Pharmaceuticals Inc. Arminothiazole derivatives as human stearoyl-coa desaturase inhibitors
AU2009264242A1 (en) * 2008-06-27 2009-12-30 Novartis Ag Organic compounds
US9422252B2 (en) 2012-05-22 2016-08-23 Autifony Therapeutics Limited Triazoles as Kv3 inhibitors
EP3464262B1 (en) * 2016-05-27 2020-02-26 Bristol-Myers Squibb Company Triazolones and tetrazolones as inhibitors of rock

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT311956B (de) * 1971-06-07 1973-12-10 Boehringer Sohn Ingelheim Verfahren zur Herstellung neuer Phenylimidazolidinonderivate und ihrer Salze
US4791111A (en) * 1985-12-23 1988-12-13 Janssen Pharmaceutica, N.V. [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles having anti-microbial properties
CA1331757C (en) * 1988-02-29 1994-08-30 Janssen Pharmaceutica Naamloze Vennootschap 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols
CA2076257A1 (en) * 1991-09-13 1993-03-14 Jan Heeres 4-¬4-¬4-(4-hydroxyphenyl)-1- piperazinyl|phenyl|-5-methyl-3h -1,2,4-triazol-3-one derivatives
TW279864B (es) * 1993-02-19 1996-07-01 Janssen Pharmaceutica Nv

Also Published As

Publication number Publication date
ZA955753B (en) 1997-01-11
NO310289B1 (no) 2001-06-18
HU9700077D0 (en) 1997-02-28
CA2194563A1 (en) 1996-01-25
US5607932A (en) 1997-03-04
JPH10502383A (ja) 1998-03-03
NO970086L (no) 1997-03-10
EP0770073A1 (en) 1997-05-02
HUT76641A (en) 1997-10-28
PL318142A1 (en) 1997-05-12
IL114534A0 (en) 1995-11-27
CN1067999C (zh) 2001-07-04
NZ290116A (en) 1997-11-24
NO970086D0 (no) 1997-01-09
WO1996001821A1 (en) 1996-01-25
RU2152940C1 (ru) 2000-07-20
CZ2697A3 (en) 1997-09-17
FI970110A7 (fi) 1997-01-10
CN1152310A (zh) 1997-06-18
AU3075595A (en) 1996-02-09
BR9508380A (pt) 1997-12-23
FI970110A0 (fi) 1997-01-10
AU684986B2 (en) 1998-01-08
IL114534A (en) 1999-08-17
MY131785A (en) 2007-08-30
SK2197A3 (en) 1997-11-05

Similar Documents

Publication Publication Date Title
MX9700338A (es) Derivados heterociclicos de azolona anti-helicobacter.
MX9700340A (es) Agentes anti-helicobacter derivados sulfonamida de azolonas.
AR005706A1 (es) Inhibidores egfr de 4-aminoquinzolina, procedimiento para su obtencion, composicion farmaceutica que los contiene, uso de los mismos para lapreparacion de un medicamento util como agente antineoplasico
AR023727A1 (es) Compuestos empleados en el tratamiento de padecimientos inflamatorios
SE8200916L (sv) Karbostyrilderivat, forfarande for framstellning derav och hjertsterkande komposition som innehaller detsamma
AR032361A1 (es) Derivados de androstano y sales y solvatos de los mismos, su uso para la fabricacion de medicamentos, composiciones farmaceuticas que comprenden tales compuestos, proceso para la preparacion de dichos compuestos, e intermediarios utiles en la preparacion de tales compuestos
ES2056190T3 (es) Derivados de 4(4-fenil-1-piperazinil)fenoles, inhibidores de 5-lipoxigenasa.
AR029301A1 (es) Compuestos derivados de biarilo, metodos para su preparacion composiciones que los contienen, su uso como agonistas en receptores beta-adreno-receptores atipicos
ES2171884T3 (es) Compuestos de quinazolina.
CL2021002805A1 (es) Derivados de 1,1-dióxido de 3-amino-4h-benzo[e][1,2,4] tiadiazina como inhibidores de mrgx2
CL2003002756A1 (es) Compuestos derivados de (1-carbamoil-1,1-defenilmetil)-1-[substituido)alquil]purrolidinas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento del sindrome de intestino irritable o incontinencia.
AR027402A1 (es) Derivados de pirimidina.
AR002012A1 (es) Un compuesto, una composicion farmaceutica que lo comprende, su uso, metodo de tratamiento terapeutico, metodo para la preparacion del compuesto.
ES2153907T3 (es) Compuestos espiro tetraciclicos, procedimiento para su preparacion y su uso como antagonistas del receptor 5ht1d.
PA8432901A1 (es) Compuestos de piridilpirrol
ES8507534A1 (es) Procedimiento para la preparacion de derivados benzopiranicos
PE20030208A1 (es) Derivados de indirubina que contienen azufre, su preparacion y uso
AR072809A1 (es) Compuesto de (3- piridinilcarbonil)-4-(fenilsulfonilpiperazina ), su uso para la elaboracion de unmedicamento para el tratamiento del dolor y composicion farmaceutica que lo comprende
PA8458301A1 (es) 2-aminopiridinas con sustituyentes alcoxi ramificados
AR037347A1 (es) Derivados de triazol
RO86083A2 (ro) Procedeu pentru prepararea unor derivati de benzamida
ES2059534T3 (es) Nuevos derivados benzopiranos antihipertensivos.
AR031071A1 (es) Derivados de la dihidrobenzodiazepina, un procedimiento para su preparacion , el uso de los mismos para preparar un medicamento y las composiciones farmaceuticas que contienen estos compuestos
AR031486A1 (es) Derivados de pirimidina
DK420682A (da) Fremgangsmaade til fremstilling af triazoloquinazoloner eller salte deraf